
|Articles|March 1, 1997
The American Journal of Managed Care
- March 1997
- Volume 3
- Issue 3
A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine
Advertisement
Articles in this issue
over 28 years ago
The Political Economy of Capitated Managed Careover 28 years ago
Appropriate and Necessary Healthcare: New Language for a New Eraover 28 years ago
Managing Asthma CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
5 Expanded FDA Approvals From October
3
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
4
Trial Data Yield Risk-Based NRSTS Treatment Strategies
5















































